研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2019 年的期刊文章
共 1232 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2019-12-31 到 2019-12-16。
按期刊看(展开)
- JASA Journal of the American Statistical Association · 180 篇
- AoS Annals of Statistics · 121 篇
- JRSSB Journal of the Royal Statistical Society Series B · 35 篇
- Biometrika Biometrika · 75 篇
- Biometrics Biometrics · 139 篇
- SiM Statistics in Medicine · 297 篇
- SMMR Statistical Methods in Medical Research · 142 篇
- JMLR Journal of Machine Learning Research · 184 篇
- Econometrica Econometrica · 59 篇
按主题看(展开)
Biometrics Latent Variables & Mixtures Nonparametric & Semiparametric · 发表于 2019-12-31
Rui Duan, Yang Ning, Shuang Wang, Bruce G. Lindsay, Raymond J. Carroll, Yong Chen
摘要
In biomedical studies, testing for homogeneity between two groups, where one group is modeled by mixture models, is often of great interest. This paper considers the semiparametric exponential family mixture model proposed by Honget al. (2017) and studies the score test for homogeneity under this model. The score test is nonregular in the sense that nuisance parameters disappear under the null hypothesis. To address this difficulty, we propose a modification of the score test, so that the resulting test enjoys the Wilks phenomenon. In finite samples, we show that with fixed nuisance parameters the score test is locally most powerful. In large samples, we establish the asymptotic power functions under two types of local alternative hypotheses. Our simulation studies illustrate that the proposed score test is powerful and computationally fast. We apply the proposed score test to an UK ovarian cancer DNA methylation data for identification of differentially methylated CpG sites.
SiM High-Dimensional Diagnostics & Prediction Nonparametric & Semiparametric · 发表于 2019-12-27
Xiaochen Zhang, Qingzhao Zhang, Xiaofeng Wang, Shuangge Ma, Kuangnan Fang
摘要
This article is motivated by a study of lung cancer prediction using breath volatile organic compound (VOC) biomarkers, where the challenge is that the predictors include not only high‐dimensional time‐dependent or functional VOC features but also the time‐independent clinical variables. We consider a high‐dimensional logistic regression and propose two different penalties:group spline‐penaltyorgroup smooth‐penaltyto handle the group structures of the time‐dependent variables in the model. The new methods have the advantage for the situation where the model coefficients are sparse but change smoothly within the group, compared with other existing methods such as the group lasso and the group bridge approaches. Our methods are easy to implement since they can be turned into a group minimax concave penalty problem after certain transformations. We show that our fitting algorithm possesses the descent property and leads to attractive convergence properties. The simulation studies and the lung cancer application are performed to demonstrate the accuracy and stability of the proposed approaches.
SiM Causal Inference Latent Variables & Mixtures Testing & Uncertainty · 发表于 2019-12-27
Xueying Wang, Lang Li, Lei Wang, Weixing Feng, Pengyue Zhang
摘要
With increasing trend of polypharmacy, drug‐drug interaction (DDI)‐induced adverse drug events (ADEs) are considered as a major challenge for clinical practice. As premarketing clinical trials usually have stringent inclusion/exclusion criteria, limited comedication data capture and often times small sample size have limited values in study DDIs. On the other hand, ADE reports collected by spontaneous reporting system (SRS) become an important source for DDI studies. There are two major challenges in detecting DDI signals from SRS: confounding bias and false positive rate. In this article, we propose a novel approach, propensity score‐adjusted three‐component mixture model (PS‐3CMM). This model can simultaneously adjust for confounding bias and estimate false discovery rate for all drug‐drug‐ADE combinations in FDA Adverse Event Reporting System (FAERS), which is a preeminent SRS database. In simulation studies, PS‐3CMM performs better in detecting true DDIs comparing to the existing approach. It is more sensitive in selecting the DDI signals that have nonpositive individual drug relative ADE risk (NPIRR). The application of PS‐3CMM is illustrated in analyzing the FAERS database. Compared to the existing approaches, PS‐3CMM prioritizes DDI signals differently. PS‐3CMM gives high priorities to DDI signals that have NPIRR. Both simulation studies and FAERS data analysis conclude that our new PS‐3CMM is a new method that is complement to the existing DDI signal detection methods.
SiM Causal Inference Survival Analysis Nonparametric & Semiparametric · 发表于 2019-12-27
Yen‐Tsung Huang
摘要
Mendelian randomization (MR) uses genetic information as an instrumental variable (IV) to estimate the causal effect of an exposure of interest on an outcome in the presence of unknown confounding. We are interested in the causal effect of cigarette smoking on lung cancer survival, which is subject to confounding by underlying pulmonary functions. Despite the well‐developed IV analyses for the continuous and binary outcomes, the scarcity of methodology for the survival outcome limits its utility for the time‐to‐event data collected in many observational studies. We propose an IV analysis method in the survival context, estimating causal effects on a transformed survival time and survival probabilities using semiparametric linear transformation models. We study the conditions under which hazard ratio and the effect on survival probability can be approximated. For statistical inference, we construct estimating equations to circumvent the difficulty in deriving joint likelihood of the exposure and the outcome, due to the unknown confounding. Asymptotic properties of the proposed estimators are established without parametric assumptions about confounders. We study the finite sample performance in extensive simulation studies. The MR analysis of a lung cancer study suggests a harmful prognostic effect of smoking pack‐years that would have been missed by the crude association.
Biometrics Genetics & Omics · 发表于 2019-12-27
Wei Sun, Chong Jin, Jonathan A. Gelfond, Ming‐Hui Chen, Joseph G. Ibrahim
摘要
Many computational methods have been developed to discern intratumor heterogeneity (ITH) using DNA sequence data from bulk tumor samples. These methods share an assumption that two mutations arise from the same subclone if they have similar mutant allele‐frequencies (MAFs), and thus it is difficult or impossible to distinguish two subclones with similar MAFs. Single‐cell DNA sequencing (scDNA‐seq) data can be very informative for ITH inference. However, due to the difficulty of DNA amplification, scDNA‐seq data are often very noisy. A promising new study design is to collect both bulk and single‐cell DNA‐seq data and jointly analyze them to mitigate the limitations of each data type. To address the analytic challenges of this new study design, we propose a computational method named BaSiC (Bulk tumor and Single Cell), to discern ITH by jointly analyzing DNA‐seq data from bulk tumor and single cells. We demonstrate that BaSiC has comparable or better performance than the methods using either data type. We further evaluate BaSiC using bulk tumor and single‐cell DNA‐seq data from a breast cancer patient and several leukemia patients.
Biometrics Networks & Graphs Diagnostics & Prediction Causal Inference · 发表于 2019-12-27
Shanghong Xie, Xiang Li, Peter McColgan, Rachael I. Scahill, Donglin Zeng, Yuanjia Wang
摘要
Biomarkers are often organized into networks, in which the strengths of network connections vary across subjects depending on subject‐specific covariates (eg, genetic variants). Variation of network connections, as subject‐specific feature variables, has been found to predict disease clinical outcome. In this work, we develop a two‐stage method to estimate biomarker networks that account for heterogeneity among subjects and evaluate network's association with disease clinical outcome. In the first stage, we propose a conditional Gaussian graphical model with mean and precision matrix depending on covariates to obtain covariate‐dependent networks with connection strengths varying across subjects while assuming homogeneous network structure. In the second stage, we evaluate clinical utility of network measures (connection strengths) estimated from the first stage. The second‐stage analysis provides the relative predictive power of between‐region network measures on clinical impairment in the context of regional biomarkers and existing disease risk factors. We assess the performance of proposed method by extensive simulation studies and application to a Huntington's disease (HD) study to investigate the effect of HD causal gene on the rate of change in motor symptom through affecting brain subcortical and cortical gray matter atrophy connections. We show that cortical network connections and subcortical volumes, but not subcortical connections are identified to be predictive of clinical motor function deterioration. We validate these findings in an independent HD study. Lastly, highly similar patterns seen in the gray matter connections and a previous white matter connectivity study suggest a shared biological mechanism for HD and support the hypothesis that white matter loss is a direct result of neuronal loss as opposed to the loss of myelin or dysmyelination.
SMMR Genetics & Omics · 发表于 2019-12-27
Marianne A Jonker, Priya Vart, Mar Rodriguez Girondo
摘要
Information on the age at onset distribution of the asymptomatic stage of a disease can be of paramount importance in early detection and timely management of that disease. However, accurately estimating this distribution is challenging, because the asymptomatic stage is difficult to recognize for the patient and is often detected as an incidental finding or in case of recommended screening; the age at onset is often interval-censored. In this paper, we propose a method for the estimation of the age at onset distribution of the asymptomatic stage of a genetic disease based on ascertained pedigree data that take into account the way the data are ascertained to overcome selection bias. Simulation studies show that the estimates seem to be asymptotically unbiased. Our work is motivated by the analysis of data on facioscapulohumeral muscular dystrophy, a genetic muscle disorder. In our application, carriers of the genetic causal variant are identified through genetic screening of the relatives of symptomatic carriers and their disease status is determined by a medical examination. The estimates reveal an early age at onset of the asymptomatic stage of facioscapulohumeral muscular dystrophy.
SiM Clinical Trials Longitudinal Data Causal Inference · 发表于 2019-12-26
Lee Kennedy‐Shaffer, Victor de Gruttola, Marc Lipsitch
摘要
Stepped wedge cluster randomized trials (SW‐CRTs) have become increasingly popular and are used for a variety of interventions and outcomes, often chosen for their feasibility advantages. SW‐CRTs must account for time trends in the outcome because of the staggered rollout of the intervention. Robust inference procedures and nonparametric analysis methods have recently been proposed to handle such trends without requiring strong parametric modeling assumptions, but these are less powerful than model‐based approaches. We propose several novel analysis methods that reduce reliance on modeling assumptions while preserving some of the increased power provided by the use of mixed effects models. In one method, we use the synthetic control approach to find the best matching clusters for a given intervention cluster. Another method makes use of within‐cluster crossover information to construct an overall estimator. We also consider methods that combine these approaches to further improve power. We test these methods on simulated SW‐CRTs, describing scenarios in which these methods have increased power compared with existing nonparametric methods while preserving nominal validity when mixed effects models are misspecified. We also demonstrate theoretical properties of these estimators with less restrictive assumptions than mixed effects models. Finally, we propose avenues for future research on the use of these methods; motivation for such research arises from their flexibility, which allows the identification of specific causal contrasts of interest, their robustness, and the potential for incorporating covariates to further increase power. Investigators conducting SW‐CRTs might well consider such methods when common modeling assumptions may not hold.
Biometrics Survival Analysis Causal Inference Clinical Trials · 发表于 2019-12-26
Yasuhiro Hagiwara, Tomohiro Shinozaki, Yutaka Matsuyama
摘要
G‐estimation of structural nested models (SNMs) plays an important role in estimating the effects of time‐varying treatments with appropriate adjustment for time‐dependent confounding. As SNMs for a failure time outcome, structural nested accelerated failure time models (SNAFTMs) and structural nested cumulative failure time models have been developed. The latter models are included in the class of structural nested mean models (SNMMs) and are not involved in artificial censoring, which induces several difficulties in g‐estimation of SNAFTMs. Recently, restricted mean time lost (RMTL), which corresponds to the area under a distribution function up to a restriction time, is attracting attention in clinical trial communities as an appropriate summary measure of a failure time outcome. In this study, we propose another SNMM for a failure time outcome, which is called structural nested RMTL model (SNRMTLM) and describe randomized and observational g‐estimation procedures that use different assumptions for the treatment mechanism in a randomized trial setting. We also provide methods to estimate marginal RMTLs under static treatment regimes using estimated SNRMTLMs. A simulation study evaluates finite‐sample performances of the proposed methods compared with the conventional intention‐to‐treat and per‐protocol analyses. We illustrate the proposed methods using data from a randomized controlled trial for cardiovascular disease with treatment changes. G‐estimation of SNRMTLMs is a useful tool to estimate the effects of time‐varying treatments on a failure time outcome.
SiM Spatial & Time Series · 发表于 2019-12-26
Xanthi Pedeli, Dimitris Karlis
摘要
In recent days, different types of surveillance data are becoming available for public health purposes. In most cases, several variables are monitored and events of different types are reported. As the amount of surveillance data increases, statistical methods that can effectively address multivariate surveillance scenarios are demanded. Even though research activity in this field is increasing rapidly in recent years, only a few approaches have simultaneously addressed the integer‐valued property of the data and its correlation (both time correlation and cross‐correlation) structure. In this article, we suggest a multivariate integer‐valued autoregressive model that allows for both serial and cross‐correlations between the series and can easily accommodate overdispersion and covariate information. Moreover, its structure implies a natural decomposition into an endemic and an epidemic component, a common distinction in dynamic models for infectious disease counts. Detection of disease outbreaks is achieved through the comparison of surveillance data with one‐step‐ahead predictions obtained after fitting the suggested model to a set of clean historical data. The performance of the suggested model is illustrated on a trivariate series of syndromic surveillance data collected during Athens 2004 Olympic Games.
Biometrics Diagnostics & Prediction · 发表于 2019-12-25
Yanqing Wang, Ying‐Qi Zhao, Yingye Zheng
摘要
Novel biomarkers, in combination with currently available clinical information, have been sought to improve clinical decision making in many branches of medicine, including screening, surveillance, and prognosis. Statistical methods are needed to integrate such diverse information to develop targeted interventions that balance benefit and harm. In the specific setting of disease detection, we propose novel approaches to construct a multiple‐marker‐based decision rule by directly optimizing a benefit function, while controlling harm at a maximally tolerable level. These new approaches include plug‐in and direct‐optimization‐based algorithms, and they allow for the construction of both nonparametric and parametric rules. A study of asymptotic properties of the proposed estimators is provided. Simulation results demonstrate good clinical utilities for the resulting decision rules under various scenarios. The methods are applied to a biomarker study in prostate cancer surveillance.
Biometrika Bayesian Methods · 发表于 2019-12-24
D B Dunson, J E Johndrow
摘要
Summary: In a 1970 Biometrika paper, W. K. Hastings developed a broad class of Markov chain algorithms for sampling from probability distributions that are difficult to sample from directly. The algorithm draws a candidate value from a proposal distribution and accepts the candidate with a probability that can be computed using only the unnormalized density of the target distribution, allowing one to sample from distributions known only up to a constant of proportionality. The stationary distribution of the corresponding Markov chain is the target distribution one is attempting to sample from. The Hastings algorithm generalizes the Metropolis algorithm to allow a much broader class of proposal distributions instead of just symmetric cases. An important class of applications for the Hastings algorithm corresponds to sampling from Bayesian posterior distributions, which have densities given by a prior density multiplied by a likelihood function and divided by a normalizing constant equal to the marginal likelihood. The marginal likelihood is typically intractable, presenting a fundamental barrier to implementation in Bayesian statistics. This barrier can be overcome by Markov chain Monte Carlo sampling algorithms. Amazingly, even after 50 years, the majority of algorithms used in practice today involve the Hastings algorithm. This article provides a brief celebration of the continuing impact of this ingenious algorithm on the 50th anniversary of its publication.
Biometrika Causal Inference Nonparametric & Semiparametric Clinical Trials · 发表于 2019-12-24
Xuan Wang, Layla Parast, Lu Tian, Tianxi Cai
摘要
Summary: In randomized clinical trials, the primary outcome, $Y$, often requires long-term follow-up and/or is costly to measure. For such settings, it is desirable to use a surrogate marker, $S$, to infer the treatment effect on $Y$, $\Delta$. Identifying such an $S$ and quantifying the proportion of treatment effect on $Y$ explained by the effect on $S$ are thus of great importance. Most existing methods for quantifying the proportion of treatment effect are model based and may yield biased estimates under model misspecification. Recently proposed nonparametric methods require strong assumptions to ensure that the proportion of treatment effect is in the range $[0,1]$. Additionally, optimal use of $S$ to approximate $\Delta$ is especially important when $S$ relates to $Y$ nonlinearly. In this paper we identify an optimal transformation of $S$, $g_{\tiny {\rm{opt}}}(\cdot)$, such that the proportion of treatment effect explained can be inferred based on $g_{\tiny {\rm{opt}}}(S)$. In addition, we provide two novel model-free definitions of proportion of treatment effect explained and simple conditions for ensuring that it lies within $[0,1]$. We provide nonparametric estimation procedures and establish asymptotic properties of the proposed estimators. Simulation studies demonstrate that the proposed methods perform well in finite samples. We illustrate the proposed procedures using a randomized study of HIV patients.
Biometrika Bayesian Methods · 发表于 2019-12-24
Leo L Duan, Alexander L Young, Akihiko Nishimura, David B Dunson
摘要
Summary: Prior information often takes the form of parameter constraints. Bayesian methods include such information through prior distributions having constrained support. By using posterior sampling algorithms, one can quantify uncertainty without relying on asymptotic approximations. However, sharply constrained priors are not necessary in some settings and tend to limit modelling scope to a narrow set of distributions that are tractable computationally. We propose to replace the sharp indicator function of the constraint with an exponential kernel, thereby creating a close-to-constrained neighbourhood within the Euclidean space in which the constrained subspace is embedded. This kernel decays with distance from the constrained space at a rate depending on a relaxation hyperparameter. By avoiding the sharp constraint, we enable use of off-the-shelf posterior sampling algorithms, such as Hamiltonian Monte Carlo, facilitating automatic computation in a broad range of models. We study the constrained and relaxed distributions under multiple settings and theoretically quantify their differences. Application of the method is illustrated through several novel modelling examples.
Biometrics Survival Analysis Clinical Trials · 发表于 2019-12-23
Godwin Yung, Yi Liu
摘要
Asymptotic distributions under alternative hypotheses and their corresponding sample size and power equations are derived for nonparametric test statistics commonly used to compare two survival curves. Test statistics include the weighted log‐rank test and the Wald test for difference in (or ratio of) Kaplan‐Meier survival probability, percentile survival, and restricted mean survival time. Accrual, survival, and loss to follow‐up are allowed to follow any arbitrary continuous distribution. We show that Schoenfeld's equation—often used by practitioners to calculate the required number of events for the unweighted log‐rank test—can be inaccurate even when the proportional hazards (PH) assumption holds. In fact, it can mislead one to believe that 1:1 is the optimal randomization ratio (RR), when actually power can be gained by assigning more patients to the active arm. Meaningful improvements to Schoenfeld's equation are made. The present theory should be useful in designing clinical trials, particularly in immuno‐oncology where nonproportional hazards are frequently encountered. We illustrate the application of our theory with an example exploring optimal RR under PH and a second example examining the impact of delayed treatment effect. A companion R package npsurvSS is available for download on CRAN.
SiM Nonparametric & Semiparametric Genetics & Omics · 发表于 2019-12-23
Fodé Tounkara, Geneviève Lefebvre, Celia Greenwood, Karim Oualkacha
摘要
Data collected for a genome‐wide association study of a primary phenotype are often used for additional genome‐wide association analyses of secondary phenotypes. However, when the primary and secondary traits are dependent, naïve analyses of secondary phenotypes may induce spurious associations in non‐randomly ascertained samples. Previously, retrospective likelihood‐based methods have been proposed to correct for sampling biases arising in secondary trait association analyses. However, most methods have been introduced to handle studies featuring a case‐control design based on a binary primary phenotype. As such, these methods are not directly applicable to more complicated study designs such as multiple‐trait studies, where the sampling mechanism also depends on the secondary phenotype, or extreme‐trait studies, where individuals with extreme primary phenotype values are selected. To accommodate these more complicated sampling mechanisms, only a few prospective likelihood approaches have been proposed. These approaches assume a normal distribution for the secondary phenotype (or the latent secondary phenotype) and a bivariate normal distribution for the primary‐secondary phenotype dependence. In this paper, we propose a unified copula‐based approach to appropriately detect genetic variant/secondary phenotype association in the presence of selected samples. Primary phenotype is either binary or continuous and the secondary phenotype is continuous although not necessary normal. We use both prospective and retrospective likelihoods to account for the sampling mechanism and use a copula model to allow for potentially different dependence structures between the primary and secondary phenotypes. We demonstrate the effectiveness of our approach through simulation studies and by analyzing data from the Avon Longitudinal Study of Parents and Children cohort.
SMMR Nonparametric & Semiparametric · 发表于 2019-12-22
Wen Li, Ruosha Li, Ziding Feng, Jing Ning
摘要
Two-phase sampling designs, including nested case-control and case-cohort designs, are frequently utilized in large cohort studies involving expensive biomarkers. To analyze data from two-phase designs with a binary outcome, parametric models such as logistic regression are often adopted. However, when the model assumptions are not valid, parametric models may lead to biased estimation and risk evaluation. In this paper, we propose a robust semiparametric regression model for binary outcomes and an easy-to-implement computational procedure that combines the pool-adjacent violators algorithm with inverse probability weighting. The asymptotic properties are established, including consistency and the convergence rate. Simulation studies show that the proposed method performs well and is more robust than logistic regression methods. We demonstrate the application of the proposed method to real data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Biometrika Networks & Graphs · 发表于 2019-12-22
Jing Lei, Kehui Chen, Brian Lynch
摘要
Summary: We consider multi-layer network data where the relationships between pairs of elements are reflected in multiple modalities, and may be described by multivariate or even high-dimensional vectors. Under the multi-layer stochastic block model framework we derive consistency results for a least squares estimation of memberships. Our theorems show that, as compared to single-layer community detection, a multi-layer network provides much richer information that allows for consistent community detection from a much sparser network, with required edge density reduced by a factor of the square root of the number of layers. Moreover, the multi-layer framework can detect cohesive community structure across layers, which might be hard to detect by any single-layer or simple aggregation. Simulations and a data example are provided to support the theoretical results.
SMMR Survival Analysis Nonparametric & Semiparametric · 发表于 2019-12-22
Takeshi Emura, Jia-Han Shih, Il Do Ha, Ralf A Wilke
摘要
For the analysis of competing risks data, three different types of hazard functions have been considered in the literature, namely the cause-specific hazard, the sub-distribution hazard, and the marginal hazard function. Accordingly, medical researchers can fit three different types of the Cox model to estimate the effect of covariates on each of the hazard function. While the relationship between the cause-specific hazard and the sub-distribution hazard has been extensively studied, the relationship to the marginal hazard function has not yet been analyzed due to the difficulties related to non-identifiability. In this paper, we adopt an assumed copula model to deal with the model identifiability issue, making it possible to establish a relationship between the sub-distribution hazard and the marginal hazard function. We then compare the two methods of fitting the Cox model to competing risks data. We also extend our comparative analysis to clustered competing risks data that are frequently used in medical studies. To facilitate the numerical comparison, we implement the computing algorithm for marginal Cox regression with clustered competing risks data in the R joint.Cox package and check its performance via simulations. For illustration, we analyze two survival datasets from lung cancer and bladder cancer patients.
SiM Bayesian Methods High-Dimensional Nonparametric & Semiparametric · 发表于 2019-12-21
Jie Ren, Fei Zhou, Xiaoxi Li, Qi Chen, Hongmei Zhang, Shuangge Ma, Yu Jiang, Cen Wu
摘要
Many complex diseases are known to be affected by the interactions between genetic variants and environmental exposures beyond the main genetic and environmental effects. Study of gene‐environment (G×E) interactions is important for elucidating the disease etiology. Existing Bayesian methods for G×E interaction studies are challenged by the high‐dimensional nature of the study and the complexity of environmental influences. Many studies have shown the advantages of penalization methods in detecting G×E interactions in “large p, small n” settings. However, Bayesian variable selection, which can provide fresh insight into G×E study, has not been widely examined. We propose a novel and powerful semiparametric Bayesian variable selection model that can investigate linear and nonlinear G×E interactions simultaneously. Furthermore, the proposed method can conduct structural identification by distinguishing nonlinear interactions from main‐effects‐only case within the Bayesian framework. Spike‐and‐slab priors are incorporated on both individual and group levels to identify the sparse main and interaction effects. The proposed method conducts Bayesian variable selection more efficiently than existing methods. Simulation shows that the proposed model outperforms competing alternatives in terms of both identification and prediction. The proposed Bayesian method leads to the identification of main and interaction effects with important implications in a high‐throughput profiling study with high‐dimensional SNP data.
SiM Diagnostics & Prediction Causal Inference · 发表于 2019-12-21
Julia Krzykalla, Axel Benner, Annette Kopp‐Schneider
摘要
One of the main endeavours in present‐day medicine, especially in oncological research, is to provide evidence for individual treatment decisions (“stratified medicine”). In the pursuit of optimal treatment decision rules, the identification of predictive biomarkers that modify the treatment effect is essential. Proposed methods have often been based on recursive partitioning since a wide variety of interaction patterns can be captured automatically and the results are easily interpretable. Furthermore, these methods are readily extendable to high‐dimensional settings by means of ensemble learning. In this article, we present predMOB, an adaptation of the model‐based recursive partitioning (MOB) for subgroup analysis approach specifically tailored to the identification of predictive factors. In a simulation study, predMOB outperforms the original MOB with respect to the number of false detections and shows to be more robust in moderately complex settings. Furthermore, we compare the results of predMOB for the application to a public data base of amyotrophic lateral sclerosis patients to those obtained from the original MOB and are able to elucidate the nature of the biomarkers' effects.
SiM Genetics & Omics · 发表于 2019-12-20
Lauren J. Beesley, Maxwell Salvatore, Lars G. Fritsche, Anita Pandit, Arvind Rao, Chad Brummett, Cristen J. Willer, Lynda D. Lisabeth, Bhramar Mukherjee
摘要
Biobanks linked to electronic health records provide rich resources for health‐related research. With improvements in administrative and informatics infrastructure, the availability and utility of data from biobanks have dramatically increased. In this paper, we first aim to characterize the current landscape of available biobanks and to describe specific biobanks, including their place of origin, size, and data types. The development and accessibility of large‐scale biorepositories provide the opportunity to accelerate agnostic searches, expedite discoveries, and conduct hypothesis‐generating studies of disease‐treatment, disease‐exposure, and disease‐gene associations. Rather than designing and implementing a single study focused on a few targeted hypotheses, researchers can potentially use biobanks' existing resources to answer an expanded selection of exploratory questions as quickly as they can analyze them. However, there are many obvious and subtle challenges with the design and analysis of biobank‐based studies. Our second aim is to discuss statistical issues related to biobank research such as study design, sampling strategy, phenotype identification, and missing data. We focus our discussion on biobanks that are linked to electronic health records. Some of the analytic issues are illustrated using data from the Michigan Genomics Initiative and UK Biobank, two biobanks with two different recruitment mechanisms. We summarize the current body of literature for addressing these challenges and discuss some standing open problems. This work complements and extends recent reviews about biobank‐based research and serves as a resource catalog with analytical and practical guidance for statisticians, epidemiologists, and other medical researchers pursuing research using biobanks.
SiM Clinical Trials · 发表于 2019-12-20
Pavel Mozgunov, Thomas Jaki
摘要
This article proposes a novel criterion for the allocation of patients in phase I dose‐escalation clinical trials, aiming to find the maximum tolerated dose (MTD). Conventionally, using a model‐based approach, the next patient is allocated to the dose with the toxicity estimate closest (in terms of the absolute or squared distance) to the maximum acceptable toxicity. This approach, however, ignores the uncertainty in point estimates and ethical concerns of assigning a lot of patients to overly toxic doses. In fact, balancing the trade‐off between how accurately the MTD can be estimated and how many patients would experience adverse events is one of the primary challenges in phase I studies. Motivated by recent discussions in the theory of estimation in restricted parameter spaces, we propose a criterion that allows to balance these explicitly. The criterion requires a specification of one additional parameter only that has a simple and intuitive interpretation. We incorporate the proposed criterion into the one‐parameter Bayesian continual reassessment method and show, using simulations, that it can result in similar accuracy on average as the original design, but with fewer toxic responses on average. A comparison with other model‐based dose‐escalation designs, such as escalation with overdose control and its modifications, demonstrates that the proposed design can result in either the same mean accuracy as alternatives but fewer toxic responses or in a higher mean accuracy but the same number of toxic responses. Therefore, the proposed design can provide a better trade‐off between the accuracy and the number of patients experiencing adverse events, making the design a more ethical alternative over some of the existing methods for phase I trials.
SiM Survival Analysis Latent Variables & Mixtures · 发表于 2019-12-19
Amy Ming‐Fang Yen, Hsiu‐Hsi Chen
摘要
Modeling overdetection resulting from screening often uses the conventional competing risk model. This model assigns screen‐detected cases dying from other causes as overdetection modeled by a one‐jump process, which may not be true for the censored overdetected cases. To relax this restrictive assumption, accommodate a finite Markov process for overdetection, and dispense with long‐term follow‐up until death, we propose a generalized Coxian phase‐type Markov process to distinguish the progressive latent multistate pathway from the nonprogressive (overdetected) latent multistate pathway. Various new likelihood functions were developed to estimate the transition parameters with the available data accrued at the time of diagnosis. The proportion of overdetected cancers by the cured model was further estimated by using parameters with and without distinguishing between the two latent pathways. While perturbation analyses were conducted by changing their parameters to assess their effects on overdetection, the results, including of asymptotic analyses, were very robust for an overdetection rate higher than 20% but not for low overdetection rates. These two scenarios were demonstrated by applying the Coxian phase‐type model to prostate cancer and breast cancer screening, yielding a substantial proportion of overdetected prostate cancer (60%) attributed to the prostate specific antigen test and a small fraction of overdetected breast cancer (3%) detected by mammography. This kind of variation in overdetection elucidated by the Coxian phase‐type Markov process provides new insights into the quantitative mechanisms producing overdetection, which is informative for evaluating the benefits and risks of various types of population‐based cancer screening programs.
Biometrics Causal Inference · 发表于 2019-12-19
Crystal T. Nguyen, Daniel J. Luckett, Anna R. Kahkoska, Grace E. Shearrer, Donna Spruijt‐Metz, Jaimie N. Davis, Michael R. Kosorok
摘要
The field of precision medicine aims to tailor treatment based on patient‐specific factors in a reproducible way. To this end, estimating an optimal individualized treatment regime (ITR) that recommends treatment decisions based on patient characteristics to maximize the mean of a prespecified outcome is of particular interest. Several methods have been proposed for estimating an optimal ITR from clinical trial data in the parallel group setting where each subject is randomized to a single intervention. However, little work has been done in the area of estimating the optimal ITR from crossover study designs. Such designs naturally lend themselves to precision medicine since they allow for observing the response to multiple treatments for each patient. In this paper, we introduce a method for estimating the optimal ITR using data from a 2 × 2 crossover study with or without carryover effects. The proposed method is similar to policy search methods such as outcome weighted learning; however, we take advantage of the crossover design by using the difference in responses under each treatment as the observed reward. We establish Fisher and global consistency, present numerical experiments, and analyze data from a feeding trial to demonstrate the improved performance of the proposed method compared to standard methods for a parallel study design.
Biometrics Causal Inference Bayesian Methods High-Dimensional · 发表于 2019-12-19
Yanyi Song, Xiang Zhou, Min Zhang, Wei Zhao, Yongmei Liu, Sharon L. R. Kardia, Ana V. Diez Roux, Belinda L. Needham, Jennifer A. Smith, Bhramar Mukherjee
摘要
Causal mediation analysis aims to examine the role of a mediator or a group of mediators that lie in the pathway between an exposure and an outcome. Recent biomedical studies often involve a large number of potential mediators based on high‐throughput technologies. Most of the current analytic methods focus on settings with one or a moderate number of potential mediators. With the expanding growth of ‐omics data, joint analysis of molecular‐level genomics data with epidemiological data through mediation analysis is becoming more common. However, such joint analysis requires methods that can simultaneously accommodate high‐dimensional mediators and that are currently lacking. To address this problem, we develop a Bayesian inference method using continuous shrinkage priors to extend previous causal mediation analysis techniques to a high‐dimensional setting. Simulations demonstrate that our method improves the power of global mediation analysis compared to simpler alternatives and has decent performance to identify true nonnull contributions to the mediation effects of the pathway. The Bayesian method also helps us to understand the structure of the composite null cases for inactive mediators in the pathway. We applied our method to Multi‐Ethnic Study of Atherosclerosis and identified DNA methylation regions that may actively mediate the effect of socioeconomic status on cardiometabolic outcomes.
SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2019-12-19
Dean Follmann, Michael P Fay, Toshimitsu Hamasaki, Scott Evans
摘要
Composite endpoints are frequently used in clinical trials, but simple approaches, such as the time to first event, do not reflect any ordering among the endpoints. However, some endpoints, such as mortality, are worse than others. A variety of procedures have been proposed to reflect the severity of the individual endpoints such as pairwise ranking approaches, the win ratio, and the desirability of outcome ranking. When patients have different lengths of follow‐up, however, ranking can be difficult and proposed methods do not naturally lead to regression approaches and require specialized software. This paper defines an ordering scoreOto operationalize the patient ranking implied by hierarchical endpoints. We show how differential right censoring of follow‐up corresponds to multiple interval censoring of the ordering score allowing standard software for survival models to be used to calculate the nonparametric maximum likelihood estimators (NPMLEs) of different measures. Additionally, if one assumes that the ordering score is transformable to an exponential random variable, a semiparametric regression is obtained, which is equivalent to the proportional hazards model subject to multiple interval censoring. Standard software can be used for estimation. We show that the NPMLE can be poorly behaved compared to the simple estimators in staggered entry trials. We also show that the semiparametric estimator can be more efficient than simple estimators and explore how standard Cox regression maneuvers can be used to assess model fit, allow for flexible generalizations, and assess interactions of covariates with treatment. We analyze a trial of short versus long‐term antiplatelet therapy using our methods.
SiM Testing & Uncertainty Clinical Trials · 发表于 2019-12-17
Yanying Wang, William F. Rosenberger, Diane Uschner
摘要
We examine the use of randomization‐based inference for analyzing multiarmed randomized clinical trials, including the application of conditional randomization tests to multiple comparisons. The view is taken that the linkage of the statistical test to the experimental design (randomization procedure) should be recognized. A selected collection of randomization procedures generalized to multiarmed treatment allocation is summarized, and generalizations for two randomization procedures that heretofore were designed for only two treatments are developed. We explain the process of computing the randomization test and conditional randomization test via Monte Carlo simulation, developing an efficient algorithm that makes multiple comparisons possible that would not be possible using a standard algorithm, demonstrate the preservation of type I error rate, and explore the relationship of statistical power to the randomization procedure in the presence of a time trend and outliers. We distinguish between the interpretation of thep‐value in the randomization test and in the population test and verify that the randomization test can be approximated by the population test on some occasions. Data from two multiarmed clinical trials from the literature are reanalyzed to illustrate the methodology.
SiM Longitudinal Data · 发表于 2019-12-17
Rachel Nordgren, Donald Hedeker, Genevieve Dunton, Chih‐Hsiang Yang
摘要
Ecological Momentary Assessment data present some new modeling opportunities. Typically, there are sufficient data to explicitly model the within‐subject (WS) variance, and in many applications, it is of interest to allow the WS variance to depend on covariates as well as random subject effects. We describe a model that allows multiple random effects per subject in the mean model (eg, random location intercept and slopes), as well as random scale in the error variance model. We present an example of the use of this model on a real dataset and a simulation study that shows the benefit of this model, relative to simpler approaches.
SiM Causal Inference Survey & Sampling Latent Variables & Mixtures · 发表于 2019-12-17
Joseph Kang, Yulei He, Jaeyoung Hong, Precious Esie, Kyle T. Bernstein
摘要
Latent class analysis (LCA) has been effectively used to cluster multiple survey items. However, causal inference with an exposure variable, identified by an LCA model, is challenging because (1) the exposure variable is unobserved and harbors the uncertainty of estimating parameters in the LCA model and (2) confounding bias adjustments need to be done with the unobserved LCA‐driven exposure variable. In addition to these challenges, complex survey design features and survey weights must be accounted for if they are present. Our solutions to these issues are to (1) assess point estimates with the expected estimating function approach and (2) modify the survey design weights with LCA‐based propensity scores. This paper aims to introduce a statistical procedure to apply the estimating equation approach to assessing the effects of LCA‐driven cause in complex survey data using an example of the National Health and Nutrition Examination Survey.
Biometrics High-Dimensional · 发表于 2019-12-16
Farzana Afroz, Matt Parry, David Fletcher
摘要
Multinomial data arise in many areas of the life sciences, such as mark‐recapture studies and phylogenetics, and will often by overdispersed, with the variance being higher than predicted by a multinomial model. The quasi‐likelihood approach to modeling this overdispersion involves the assumption that the variance is proportional to that specified by the multinomial model. As this approach does not require specification of the full distribution of the response variable, it can be more robust than fitting a Dirichlet‐multinomial model or adding a random effect to the linear predictor. Estimation of the amount of overdispersion is often based on Pearson's statistic X2 or the deviance D. For many types of study, such as mark‐recapture, the data will be sparse. The estimator based on X2 can then be highly variable, and that based on D can have a large negative bias. We derive a new estimator, which has a smaller asymptotic variance than that based on X2, the difference being most marked for sparse data. We illustrate the numerical difference between the three estimators using a mark‐recapture study of swifts and compare their performance via a simulation study. The new estimator has the lowest root mean squared error across a range of scenarios, especially when the data are very sparse.
Biometrics Causal Inference Nonparametric & Semiparametric High-Dimensional · 发表于 2019-12-16
David Cheng, Abhishek Chakrabortty, Ashwin N. Ananthakrishnan, Tianxi Cai
摘要
We consider estimating average treatment effects (ATE) of a binary treatment in observational data when data‐driven variable selection is needed to select relevant covariates from a moderately large number of available covariates . To leverage covariates among predictive of the outcome for efficiency gain while using regularization to fit a parametric propensity score (PS) model, we consider a dimension reduction of based on fitting both working PS and outcome models using adaptive LASSO. A novel PS estimator, the Double‐index Propensity Score (DiPS), is proposed, in which the treatment status is smoothed over the linear predictors for from both the initial working models. The ATE is estimated by using the DiPS in a normalized inverse probability weighting estimator, which is found to maintain double robustness and also local semiparametric efficiency with a fixed number of covariates p. Under misspecification of working models, the smoothing step leads to gains in efficiency and robustness over traditional doubly robust estimators. These results are extended to the case where p diverges with sample size and working models are sparse. Simulations show the benefits of the approach in finite samples. We illustrate the method by estimating the ATE of statins on colorectal cancer risk in an electronic medical record study and the effect of smoking on C‐reactive protein in the Framingham Offspring Study.
Biometrics Survival Analysis · 发表于 2019-12-16
Ying Sheng, Yifei Sun, Detian Deng, Chiung‐Yu Huang
摘要
There has been a rising interest in better exploiting auxiliary summary information from large databases in the analysis of smaller‐scale studies that collect more comprehensive patient‐level information. The purpose of this paper is twofold: first, we propose a novel approach to synthesize information from both the aggregate summary statistics and the individual‐level data in censored linear regression. We show that the auxiliary information amounts to a system of nonsmooth estimating equations and thus can be combined with the conventional weighted log‐rank estimating equations by using the generalized method of moments (GMM) approach. The proposed methodology can be further extended to account for the potential inconsistency in information from different sources. Second, in the absence of auxiliary information, we propose to improve estimation efficiency by combining the overidentified weighted log‐rank estimating equations with different weight functions via the GMM framework. To deal with the nonsmooth GMM‐type objective functions, we develop an asymptotics‐guided algorithm for parameter and variance estimation. We establish the asymptotic normality of the proposed GMM‐type estimators. Simulation studies show that the proposed estimators can yield substantial efficiency gain over the conventional weighted log‐rank estimators. The proposed methods are applied to a pancreatic cancer study for illustration.
Biometrics Bayesian Methods · 发表于 2019-12-16
Marie V. Ozanne, Grant D. Brown, Angela J. Toepp, Breanna M. Scorza, Jacob J. Oleson, Mary E. Wilson, Christine A. Petersen
摘要
Zoonotic visceral leishmaniasis (ZVL) is a serious neglected tropical disease that is endemic in 98 countries. ZVL is primarily transmitted via a sand fly vector. In the United States, it is enzootic in some canine populations; it is transmitted from infectious mother to pup transplacentally, and vector‐borne transmission is absent. This absence affords a unique opportunity to study (1) vertical transmission dynamics in dogs and (2) the importance of vertical transmission in maintaining an infectious reservoir in the presence of a vector. In this paper, we present Bayesian compartmental models and reproductive number formulations to examine (1) and (2), providing a mechanism to plan and evaluate interventions in regions where both transmission modes are present. First, we propose an individual‐level susceptible, infectious, removed (SIR) model to study the effect of maternal infection status during pregnancy on pup infection progression. We provide evidence that pups born to diagnostically positive mothers during pregnancy are more likely to become diagnostically positive both earlier in life, and at some point during their lifetime, than those born to diagnostically negative mothers. Second, we propose a population‐level SIR model to study the impact of a vertically maintained reservoir on propagating infection in a naive canine population through emergent vector transmission using simulation studies. We also present reproductive numbers to quantify contributions of vertically infected and vector‐infected dogs to maintaining infection in the population. We show that a vertically maintained canine reservoir can propagate infection in a theoretical naive population in the presence of a vector.
SMMR Survival Analysis Nonparametric & Semiparametric · 发表于 2019-12-16
MC Jones, Angela Noufaily, Kevin Burke
摘要
We are concerned with the flexible parametric analysis of bivariate survival data. Elsewhere, we argued in favour of an adapted form of the ‘power generalized Weibull’ distribution as an attractive vehicle for univariate parametric survival analysis. Here, we additionally observe a frailty relationship between a power generalized Weibull distribution with one value of the parameter which controls distributional choice within the family and a power generalized Weibull distribution with a smaller value of that parameter. We exploit this relationship to propose a bivariate shared frailty model with power generalized Weibull marginal distributions linked by the BB9 or ‘power variance function’ copula, then change it to have adapted power generalized Weibull marginals in the obvious way. The particular choice of copula is, therefore, natural in the current context, and the corresponding bivariate adapted power generalized Weibull model a novel combination of pre-existing components. We provide a number of theoretical properties of the models. We also show the potential of the bivariate adapted power generalized Weibull model for practical work via an illustrative example involving a well-known retinopathy dataset, for which the analysis proves to be straightforward to implement and informative in its outcomes.